Ewa Grela

Ewa Grela

Auto-generated profile, based on publicly available information

Ewa Grela

Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Acta Histochemica
Verified
Journal Article
Closed access
EGEwa Grela
Ewa Grela
JKJoanna Kozłowska
Joanna Kozłowska
AGAgnieszka Grabowiecka
Agnieszka Grabowiecka

22 August 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KMKatarzyna Macegoniuk
Katarzyna Macegoniuk
EGEwa Grela
Ewa Grela
JPJerzy Palus
Jerzy Palus
EREwa Rudzińska-Szostak
Ewa Rudzińska-Szostak
AGAgnieszka Grabowiecka
Agnieszka Grabowiecka
ŁBŁukasz Berlicki
Łukasz Berlicki

18 October 2016 in Journal of Medical Microbiology
Verified
Journal Article
Closed access
EGEwa Grela
Ewa Grela
ADAnna Dziełak
Anna Dziełak
KSKatarzyna Szydłowska
Katarzyna Szydłowska
AMArtur Mucha
Artur Mucha
PKPaweł Kafarski
Paweł Kafarski
AGAgnieszka Grabowiecka
Agnieszka Grabowiecka
The study evaluated the in vitro impact of a series of aminophosphinic urease inhibitors on Proteus mirabilis. The group of compounds comprised structurally diverse analogues of diamidophosphate built on an N-C-P scaffold. The influence of urease inhibition on urea-splitting activity was assessed by whole-cell pH-static kinetic measurements. The potential to prevent struvite formation was determined by monitoring changes in pH and ionic composition of artificial urine medium during P. mirabilis growth. The most active compounds exhibited stronger positive effect on urine stability than the acknowledged inhibitor acetohydroxamic acid. The high anti-ureolytic and pH-stabilizing effect of urease inhibitors 4 and 14 was well correlated with their reported kinetic properties against pure urease from P. mirabilis (K i values of 0.62±0.09 and 0.202±0.057 µM, respectively, compared to 5.7±0.4 µM for acetohydroxamic acid). The effect of repressed ureolysis upon the viability of Proteus cells was studied using MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] metabolic efficiency assay and LIVE/DEAD fluorescent staining. Most of the compounds caused whole-cell dehydrogenase activity loss; four structures (1, 2, 4 and 14) reduced the culture viability by nearly 70 % at 1 mM concentration. Results of dual fluorescent staining suggested that besides urea-splitting prevention, the structures additionally exerted an outer-membrane-destabilizing effect.

9 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KMKatarzyna Macegoniuk
Katarzyna Macegoniuk
EGEwa Grela
Ewa Grela
MBMonika Biernat
Monika Biernat
MPMateusz Psurski
Mateusz Psurski
GGGrażyna Gościniak
Grażyna Gościniak
AGAgnieszka Grabowiecka
Agnieszka Grabowiecka
Urease is an important virulence factor from Helicobacter pylori that enables bacterial colonization of human gastric mucosa. Specific inhibition of urease activity can be regarded as a promising adjuvant strategy for eradication of this pathogen. A group of organophosphorus inhibitors of urease, namely, aminophosphinic acid and aminophosphonic acid derivatives, were evaluated in vitro against H. pylori urease. The kinetic characteristics of recombinant enzyme activity demonstrated a competitive reversible mode of inhibition with Ki values ranging from 0.294 to 878 μM. N-n-Hexylaminomethyl-P-aminomethylphosphinic acid and N-methylaminomethyl-P-hydroxymethylphosphinic acid were the most effective inhibitors (Ki = 0.294 μM and 1.032 μM, respectively, compared to Ki = 23 μM for the established urease inhibitor acetohydroxamic acid). The biological relevance of the inhibitors was verified in vitro against a ureolytically active Escherichia coli Rosetta host that expressed H. pylori urease and against a reference strain, H. pylori J99 (CagA+/VacA+). The majority of the studied compounds exhibited urease-inhibiting activity in these whole-cell systems. Bis(N-methylaminomethyl)phosphinic acid was found to be the most effective inhibitor in the susceptibility profile studies of H. pylori J99. The cytotoxicity of nine structurally varied inhibitors was evaluated against four normal human cell lines and was found to be negligible.

26 November 2015
Verified
Journal Article
Open access
EGEwa Grela
Ewa Grela
AZAdam Ząbek
Adam Ząbek
AGAgnieszka Grabowiecka
Agnieszka Grabowiecka
The chromogenic assay based on MTT bioreduction was adapted to Proteus mirabilis viability estimations. We primarily intended to use the assay for the evaluation of novel antimicrobial compounds, including structures with possible permeabilizing activity. Therefore, the influence of basic permeabilizing agents like Triton X-100 and EDTA upon the MTT assay was studied. 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) was used as a substrate for the whole-cell dehydrogenase activity estimations. The amount of formazan product was evaluated in the end-point reactions terminated with acidic isopropanol or in the continuous reactions run in the presence of low detergent concentrations. The generally established procedure of the end product dissolution with acidic isopropanol caused absorbance instability which strongly affected the results accuracy. The disadvantage was especially pronounced when the assay was conducted in Mueller-Hinton Broth. PBS with 0.01% Triton X-100 used as the reaction medium allowed to omit the formazan dissolution step and follow the microbial MTT reduction in a continuous mode. It was observed that in Proteus mirabilis with a compromised outer membrane the assay score was artificially increased above the untreated control. The dependence of the assay results on the cell integrity might be a major drawback of the MTT assay application for the evaluation of novel antimicrobials against Gram-negative microorganisms. On the other hand, the MTT reduction could be conveniently used to assay the permeabilization degree in biotechnological protocols.